DSGN

Conviction 69HealthcareScan · Mon, Aug 10, 2026

DSGN$14.31+2.29%

ResistanceSupportVol 14

Vol MA14 476.92K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Design Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.designtx.com ↗

Price14.31

Change+2.29%

Gap+1.43%

Rel volume1.76×

Avg volume493.59K

Avg $ vol6.28M

SMA 2012.68

SMA 5012.65

SMA 20010.84

Price vs 50+13.15%

Price vs 200+31.95%

MA stackbullish

50/200 cross—

Supertrenddown · 14.33

RSI (14)64

MACD hist0.23

MACD crossbull · 4d

Stoch %K / %D96 / 92

ADX (14)21

+DI / −DI31 / 15

RSI divergence—

MACD divergence—

ATR %+5.59%

ADR %6.09%

52w high15.79

52w low4.28

From 52w high-9.37%

Above 52w low+234.35%

New 52w highNo

SqueezeOff

Bollinger width26.46%

%B0.98

Donchian pos84.98%

Donchian high14.83

Donchian low11.37

AVWAP (52w high)12.79

vs AVWAP high+11.92%

AVWAP (52w low)11.09

vs AVWAP low+29.02%

OBV trendFlat

Chaikin MF (20)-0.04

Today vs 20d1.76×

Avg vol (14d)476.92K

Avg vol (20d)493.59K

Avg $ vol (20d)6.28M

Market cap895.54M

RS 3m (vs SPY)-6.48%

RS 6m (vs SPY)+26.49%

RS line new highNo

Trend template7/8

Technical rank85.6

1 week+12.15%

1 month-5.79%

3 months+0.63%

6 months+39.34%

1 year+260.45%

YTD+57.25%

P/E-12.83

P/B4.44

P/S—

P/FCF-16.42

EPS-1.22

Div yield—

ROE-34.57%

ROA-32.44%

Debt/Eq—

Current18.86

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-40.74%

Price target24.71

Target upside72.68%

Analyst ratingBuy

Institutional64.61%

Ent. value882.64M

Revenue20K

Net income-20.16M

Gross profit—

Free cash flow-54.55M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out62.46M

Employees54

ListedFri, Mar 26, 2021

Free float25.84M

Float %41.4%

Short interest5.67M

Days to cover6.4d

Short volume67.9%

Squeeze score95 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.32 vs −$0.36

Last surprise+11.1% beat

Setup gradeB

Conviction69 / 100

Pattern quality—

Tech rank85.6 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance15.80

Support10.91

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DSGN

All disclosures →

No recent disclosed trades by Congress in DSGN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DSGN

No recent insider (Form 4) filings in DSGN. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in DSGN · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.